Opaleye Management Inc. Essa Pharma Inc. Transaction History

Opaleye Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$7.76 - $29.37 $2.2 Million - $8.34 Million	-284,050 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$5.47 - $12.1 $69,469 - $153,670	12,700 Added 4.68%	284,050 $3.39 Million
Q3 2020 Nov 16, 2020	BUY	$6.0 - $7.79 $578,100 - $750,566	96,350 Added 55.06%	271,350 $1.87 Million
Q2 2020 Aug 14, 2020	BUY	$3.71 - $6.2 $649,250 - $1.09 Million	175,000 New	175,000 $1.09 Million

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $72.3M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.